Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Poni
    Junior Member
    • May 2012
    • 7

    Sequence mapping

    Hi,
    I want to map sequence reads into a reference gene. However, it's possible to have a higher number of SNPs and few insertions and/or deletions for this gene in the genome that I'm analyzing. May I please know which mapping software is suitable for this purpose and whether its useful to allow many mismatches?
    Your advise is highly appreciated.

    Poni
  • TiborNagy
    Senior Member
    • Mar 2010
    • 329

    #2
    I think there is no specific software for this job. Try BWA and decrease the mismatch penalty (-M).

    Comment

    • qiongyi
      Member
      • Nov 2010
      • 10

      #3
      Try BWA or bowtie2.

      Comment

      • Poni
        Junior Member
        • May 2012
        • 7

        #4
        Thanks for the suggestions.
        Poni

        Comment

        • Torst
          Senior Member
          • Apr 2008
          • 275

          #5
          Originally posted by Poni View Post
          Hi,
          I want to map sequence reads into a reference gene. However, it's possible to have a higher number of SNPs and few insertions and/or deletions for this gene in the genome that I'm analyzing. May I please know which mapping software is suitable for this purpose and whether its useful to allow many mismatches?
          Is your reference a whole genome, or just a single gene?

          Nearly all short read aligners trade sensitivity for speed. What you need is increase the sensitivity OR use a true dynamic programming aligner which implements Smith-Waterman or Needleman-Wunsch alignment. Tools which can do this are the FASTA 36 package (http://faculty.virginia.edu/wrpearson/fasta/), Exonerate with the affine model (http://www.ebi.ac.uk/~guy/exonerate/) and Needle/Water (http://emboss.sourceforge.net/).

          Personally, I would use Shrimp 2.x (http://compbio.cs.toronto.edu/shrimp/) which does well with indels.

          Comment

          • Poni
            Junior Member
            • May 2012
            • 7

            #6
            Dear Torst,
            Thanks for this discriptive reply. my reference is a single gene.
            I will try Shrimp 2.x and see.

            Thanks
            Poni

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Yesterday, 12:17 PM
            0 responses
            13 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-23-2026, 11:41 AM
            0 responses
            14 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            23 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            37 views
            0 reactions
            Last Post SEQadmin2  
            Working...